SEC 13F Intelligence

Nitorum Capital, L.P. / HAE

Nitorum Capital, L.P.’s Haemonetics Corp Mass Position

Does Nitorum Capital, L.P. own Haemonetics Corp Mass (HAE)? Not currently — the last reported position was 402.1K shares worth $48M in Q4 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$48M
Q4 2020
Shares
402.1K
% of Portfolio
+1.85%
Quarters Held
9
position exited

Position History HAE

Reported value by quarter
Q4 ’18: $25MQ4 ’18Q1 ’19: $28MQ2 ’19: $52MQ2 ’19Q3 ’19: $35MQ4 ’19: $32MQ4 ’19Q1 ’20: $39MQ2 ’20: $35MQ2 ’20Q3 ’20: $35MQ4 ’20: $48MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2020402.1K$48M+1.85%
Q3 2020400.4K$35M+1.55%
Q2 2020395.6K$35M+1.82%
Q1 2020394.1K$39M+3.04%
Q4 2019280.6K$32M+1.80%
Q3 2019279.5K$35M+2.05%
Q2 2019430.8K$52M+2.95%
Q1 2019323.7K$28M+1.87%
Q4 2018246.2K$25M+2.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nitorum Capital, L.P.’s full portfolio or all institutional holders of HAE.